Low Zva <4.3 (n=82) | High Zva ≥4.3 (n=88) | p Value | |
---|---|---|---|
Age | 77±6 | 76±6 | 0.8287 |
Male, % | 57% | 68% | 0.1427 |
HT, % | 73% | 74% | 0.9185 |
DM, % | 21% | 17% | 0.4882 |
CKD, % | 35% | 34% | 0.8162 |
CABG, % | 49% | 53% | 0.5463 |
Symptom, % | 71% | 77% | 0.3306 |
Atrial fibrillation, % | 5% | 8% | 0.5380 |
LVEF, % | 66±6 | 64±7 | 0.1664 |
E/e′ | 18±8 | 19±10 | 0.5141 |
AVA, cm2 | 0.78±0.14 | 0.64±0.12 | <0.0001 |
BP, mm Hg | 128±17 | 142±18 | <0.0001 |
MG, mm Hg | 54±13 | 59±15 | 0.0162 |
SVI, mL/cm2 | 51±7 | 40±5 | <0.0001 |
BSA, cm2 | 1.88±0.24 | 1.97±0.20 | 0.0055 |
Zva, mm Hg/mL m2 | 3.6±0.4 | 5.1±0.7 | <0.0001 |
Pulse pressure, mm Hg | 58±14 | 66±17 | 0.0007 |
SAC, mL/m2/mm Hg | 0.92±0.23 | 0.63±0.16 | <0.0001 |
AVA, aortic valve area; BP, blood pressure; BSA, body surface area; CABG, coronary artery bypass graft; CKD, chronic kidney disease; DM, diabetes mellitus; HT, hypertension: LVEF, left ventricular ejection fraction; MG, mean gradient; SAC, systemic arterial compliance; SVI, stroke volume index.